Professor Yang Baofeng’s paper published on Nature Medicine

 

 

 

 

 

 

 

 

 

Professor Yang Baofeng, President of HMU, led the research project on The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. For the first time in the world, the research team found miR-1, a new target for malignant arrhythmia. They found out its pathogenesis from the point of molecular biology, which in turn has proved that the imbalance of miRNA is the real cause of fatal arrhythmia. This original finding was published in Nature Medicine last April. Two famous international cardiophysiologists wrote a review article saying “The work of Yang is an exciting step in the dissection of new molecular signaling pathways for arrhythmias and sudden death.”


Heart failure and arrhythmia are leading causes for the death of patients with heart disease. In China, there are nearly ten million patients suffering heart failure. The four-year mortality rate after confirmed diagnosis is up to 50%. Each year there are nearly a million deaths from arrhythmias, most of which are caused by heart failure. Due to differences in genetic background, living environment and disease spectrum, some effective measures fit for the Western population are not suitable for Chinese. Meanwhile, the four main types of antiarrhythmia drugs used presently are not satisfactorily effective. The curative effect of TCM only accounts for 30-60%. Therefore, it is significant to explore the pathogenesis of heart failure and arrhythmia of Chinese population, search for new targets for antiarrhythmia drugs and establish an early warning system for major heart diseases and develop effective prevention and treatment strategies.

 

The project team led by Professor Yang Baofeng targeted this difficult and hot spot in the pharmaceutical field. Through numerous biomedical and clinical experiments, they succeeded in tracking down a new antiarrhythmia target – miRNA. MicroRNAs (miRNAs) are endogenous noncoding RNAs, about 22 nucleotides in length. The current understanding of the functions of miRNAs relies mainly on their tissue-specific or developmental stage-dependent expression and their evolutionary conservation. Their mysterious mask has not been revealed fundamentally. The team found that miR-1 expression was elevated (B2.8-fold) in RNA samples from individuals with coronary artery disease compared with those from humans with healthy hearts. To investigate whether this increase has protective or detrimental consequences, they tested RNA samples isolated from the ischemic myocardium of rat hearts that had been subjected to experimental myocardial infarction, and found a similar increase in miR-1 expression in the ischemic zone but not in the non-ischemic zone.

 

To further investigate the mechanism of miRNA, the team applied miRNA to normal in vivo model of rats through gene transfection and found that the rats suffered severer arrhythmia. When miRNA inhibitors were applied, arrhythmias were evidently reduced. If miRNA and inhibitors were applied simultaneously, the incidence of arrhythmia was reduced as well. Arrhythmia would occur if miRNA was transfected into the hearts of normal rats. The study also found that miRNA caused arrhythmia mainly through regulating certain proteins. The study has demonstrated that miRNA is the leading cause of arrhythmia. This will offer a new thinking for the treatment of arrhythmia and new drug research.

 

Nature Medicine is one of the most well-known journals in the world. Its impact factor is 28.9. Since Professor Yang’s paper was published, it has aroused international counterparts’ attention. The world famous journals such as Science, Nature and Nature Medicine and some large-scale European and American websites published commentaries. Dr. Mark E. Anderson and Dr. Peter J. Mohler, two famous cardiophysiologists, commented that “The study by Yang provides convincing evidence that miR-1 is an important regulator of electrical remodeling and arrhythmias. The findings raise hope that inhibition of miR-1 after myocardial infarction will reduce sudden death.”


This significant finding has aroused extensive attentions of the media at home and abroad. It was reported on China Central Television, major newspapers and websites.

(HMU Newspaper)